New clinical parameters for determining hematologic toxicity...

Details New clinical parameters for determining hematologic toxicity... New clinical parameters for determining hematologic toxicity...

A - Human Necessities

61

K

A61K 39/395 (2006.01) C07K 16/28 (2006.01)

Patent

CA 2378584

New clinical parameters are reported which may serve as predictors of the hematological toxicity associated with therapeutic radiolabeled antibodies, particularly those antibodies which target lymphoma cells which have a tendency to localize to the bone marrow.

L'invention concerne de nouveaux paramètres cliniques pouvant servir de prédicteurs de la toxicité hématologique associée à des anticorps thérapeutiques radiomarqués, notamment les anticorps ciblant les cellules du lymphome lesquelles ont une tendance à se localiser sur la moelle osseuse.

Affiliated with

Also associated with

Rating

New clinical parameters for determining hematologic toxicity... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with New clinical parameters for determining hematologic toxicity..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and New clinical parameters for determining hematologic toxicity... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1876053